Results of a landmark trial of 1,000.
Read More »Patients Taking Pyridorin (Pyridoxamine Dihydrochloride) Conver
The advanced glycation end product (AGE) inhibitor Pyridorin (pyridoxamine dihydrochloride) has potential in treating diabetic nephropathy.
Read More »Lowering Systolic Blood Pressure Reduces Risk of Diabetic Nephr
Reducing systolic blood pressure is critical to slowing the progression of diabetic renal disease, researchers stated at the 35th annual meeting of the American Society of Nephrology (ASN) last week.
Read More »Kidney Disease Is Related to How Well Insulin Works
Insulin resistance, a condition commonly associated with the development of type 2 diabetes, is likely a major cause of kidney disease, or nephropathy, in people with type 1 diabetes.
Read More »Anemia Neglected in People with Diabetes
Anemia affects a significant proportion of people with diabetes and is a key indicator of early kidney disease.
Read More »FDA Approves Avapro (Irbesartan) For The Treatment Of Diabetic
When patients with diabetes and kidney disease were treated with Avapro the risk of progression of their nephropathy or death was 20 percent lower.
Read More »Different Risk Factors Differentially Affect Vascular Complica
Elevated blood pressure and increased glucose levels are risk factors for the microvascular complications of type 2 diabetes. In contrast, blood pressure, but not glucose levels, appears to influence the risk of macrovascular complications.
Read More »Kidney Disease a Quiet Killer for Patients with Diabetes
“Kidney disease is an under-recognized, under-diagnosed and under-treated” Checking for urine microalbumin and protein are essential in catching it early.
Read More »